Enlivex Therapeutics Ltd. - COM (ENLV)

Historical Portfolio Holders from Q1 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
2.56M
Holdings value Q3 2024
$4.31M
Value change Q3 2024
+$807K
Grand Portfolio weight change Q3 2024
+0%
Number of holders
19
Number of buys Q3 2024
9
Number of sells Q3 2024
-2
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 2.56M $4.31M +$807K $1.68 20
2024 Q2 2.08M $2.96M +$2.16M $1.42 17
2024 Q1 326K $1.24M +$541K $3.79 15
2023 Q4 188K $509K -$102K $2.70 17
2023 Q3 258K $409K -$97.1K $1.58 17
2023 Q2 302K $795K -$107K $2.63 20
2023 Q1 343K $1.24M +$17K $3.64 19
2022 Q4 337K $1.31M +$76K $3.92 21
2022 Q3 333K $1.41M -$1.41M $4.25 20
2022 Q2 605K $2.89M -$1.29M $4.52 21
2022 Q1 846K $4.75M +$1.02M $5.60 23
2021 Q4 663K $4.12M -$1.23M $6.24 22
2021 Q3 848K $8.38M -$1.35M $9.88 23
2021 Q2 988K $8.79M -$1.5M $8.90 21
2021 Q1 1.06M $11.7M +$7.35M $11.08 24
2020 Q4 398K $3.36M +$295K $8.43 11
2020 Q3 321K $1.91M -$157K $5.93 4
2020 Q2 355K $1.8M -$3.02M $5.05 7
2020 Q1 960K $4.49M +$3.96M $4.69 6
2019 Q4 80.2K $672K -$189K $8.37 4
2019 Q3 50.8K $1.36M +$783K $26.70 4
2019 Q2 21.4K $461K +$80.4K $21.47 2
2019 Q1 17.7K $219K +$219K $12.38 1